Axogen, Inc. (AXGN) earnings
AXGN earnings moved a median of +0.43% by the close. Quarterly and annual AXGN reports and results, each read against the price at its own news timestamp. Back to the AXGN overview →
25 measured AXGN earnings events.
Where these AXGN earnings landedvs 25 measured AXGN earnings reactions
| Middle 50% of AXGN earnings reactions | -2.31% to +1.68% |
|---|---|
| Median reaction (to close) | +0.43% |
| Measured reactions | 25 |
Point-in-time · zero look-ahead
Half of the 25 AXGN earnings events with a measured close landed between -2.31% and +1.68%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Axogen, Inc. Reports Second Quarter 2026 Financial Results | Press release | +10.13% | +7.99% | |
| Form 10-Q Axogen, Inc. For: Jun 30 | SEC filing · Form 10-Q | +6.54% | +1.32% | |
| Axogen, Inc. to Report Second Quarter 2026 Financial Results on July 29, 2026 | Press release | -0.01% | -0.44% | |
| Axogen, Inc. Reports First Quarter 2026 Financial Results | Press release | +1.36% | -2.35% | |
| Form 10-Q Axogen, Inc. For: Mar 31 | SEC filing · Form 10-Q | +0.48% | +1.36% | |
| Axogen, Inc. to Report First Quarter 2026 Financial Results on April 28, 2026 | Press release | +2.05% | +2.25% | |
| Form 10-K Axogen, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.09% | -2.31% | |
| Axogen, Inc. Reports Third Quarter 2025 Financial Results | Press release | +1.48% | +17.60% | |
| Form 10-Q Axogen, Inc. For: Sep 30 | SEC filing · Form 10-Q | -3.75% | -1.00% | |
| Axogen, Inc. Reports Second Quarter 2025 Financial Results | Press release | -6.34% | -7.92% | |
| Form 10-Q Axogen, Inc. For: Jun 30 | SEC filing · Form 10-Q | +0.82% | -1.72% | |
| Form 10-Q Axogen, Inc. For: Mar 31 | SEC filing · Form 10-Q | -1.91% | -9.80% | |
| Form 10-K Axogen, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.10% | +2.26% | |
| Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA Update | Press release | -17.58% | -8.17% | |
| Form 10-Q Axogen, Inc. For: Sep 30 | SEC filing · Form 10-Q | +2.00% | -2.69% | |
| Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024 | Press release | +0.91% | +0.83% | |
| Axogen, Inc. Reports Second Quarter 2024 Financial Results | Press release | -2.95% | +1.91% | |
| Form 10-Q Axogen, Inc. For: Jun 30 | SEC filing · Form 10-Q | -1.84% | -1.17% | |
| Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024 | Press release | -0.33% | +2.50% | |
| Axogen, Inc Reports First Quarter 2024 Financial Results | Press release | +0.00% | -9.26% | |
| Form 10-Q Axogen, Inc. For: Mar 31 | SEC filing · Form 10-Q | +1.10% | -1.70% | |
| Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024 | Press release | +0.43% | +0.43% | |
| Form 10-K Axogen, Inc. For: Dec 31 | SEC filing · Form 10-K | -3.02% | +1.68% | |
| Form 10-Q Axogen, Inc. For: Sep 30 | SEC filing · Form 10-Q | -2.16% | +1.31% | |
| Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023 | Press release | +0.00% | +1.19% |
Keep exploring
More AXGN: analyst actions → · SEC filings → · AXGN overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Bruker Corporation (BRKR) | 395 | -0.10% | 46% |
| Neuronetics, Inc. (STIM) | 395 | -0.21% | 45% |
| Fulgent Genetics, Inc. (FLGT) | 393 | +0.04% | 51% |
| Kazia Therapeutics Limited - American Depositary Shares (KZIA) | 393 | -1.07% | 34% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.